Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate

BACKGROUND: QUALIFY was a 28-week, randomized, open-label, head-to-head trial that assessed improvements across multiple measures in stable patients with schizophrenia with aripiprazole once-monthly 400 mg vs paliperidone palmitate. METHODS: Secondary effectiveness assessments included physician-rat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Neuropsychopharmacol
Main Authors: Potkin, Steven G., Loze, Jean-Yves, Forray, Carlos, Baker, Ross A, Sapin, Christophe, Peters-Strickland, Timothy, Beillat, Maud, Nylander, Anna-Greta, Hertel, Peter, Nitschky Schmidt, Simon, Eramo, Anna, Hansen, Karina, Naber, Dieter
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2016
Assuntos:
Regular Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578804/
https://ncbi.nlm.nih.gov/pubmed/27927736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyw093
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares